Epidemiologist and Clinical Investigator by Charles M Fletcher CBE MD FRCP (Postgraduate Medical School ofLondon)
At first sightit would seem that the clinician in his clinic and the epidemiologist in his field survey are widely separated in activities and interests. The clinician is concerned with the diagnosis and treatment of individuals; the epidemiologist with comparing environmental or constitutional factors in groups of subjects with and without evidence of disease. In these activities each would seem to have little to contribute to or learn from the other. But when we consider their activities as a whole it becomes impossible to separate the two. First, it is illogical to compare clinical practice with epidemiological study. Epidemiology is no form of medical practice; the practical wing of epidemiology is preventive medicine and hygiene. We must compare epidemiologists with clinical investigators and here we find that, while the clinician often studies and compares groups of patients, the epidemiologist, on his side, takes clinical histories and carries out clinical examinations and investigations. He may indeed enter the hospital and compare groups of patients with each other as, for instance, in the retrospective studies of lung cancer and smoking carried out by Doll & Hill (1952) .
Nevertheless there are two important contrasts between them. The first is that the clinician has a primary and predominant interest in the mechanisms whereby the symptoms and signs of disease are produced. He has come to rely more and more on physical and chemical techniques to elucidate the ways in which the workings of the human machine are disordered by disease, and most of the therapeutic triumphs of medicine and surgery today have come from this sort of study. The clinical investigator is, in fact, concerned with the disordered mechanisms which produce the phenomena of disease in individuals. His interest in groups of patients is forced on him by the great Meeting May 171963 President's Address variation in the reaction of different individuals to the inroads of disease. It is seldom possible to conclude that any diagnostic or therapeutic measure, which appears to detect or correct the disordered mechanism in one individual, will necessarily be effective in all. But even in his group studies the clinician thinks in terms of individuals, for this is how he meets his patients. The epidemiologist differs in his approach to the groups he studies, for he thinks almost exclusively in terms of the proportion of members of a population who react in a particular way to pathogenic agents. It is because of this very interest in the measurement of disease in groups that he may be able to help the clinician whose predominant interest in the individual may occasionally lead him to fallacious generalizations.
The second contrast is that the clinician in his clinic or surgery sees only those people who come to him with some condition for which they need help, and he may never see those who do not come for help. It is true, of course, that in some conditions, such as pregnancy, those who seek help from the clinician represent nearly 100% of those affected, but in most conditions the clinician sees only a sample which is selected in unpredictable ways from all those affected. The picture of the effect of disease processes which is presented to him is therefore usually incomplete and distorted. The epidemiologist sees a truer picture in his work outside the clinic or hospital, for he studies samples of whole communities selected in such a way that they should present the complete range of manifestations of the disease processes in which he is interested. Even the epidemiologist, however, encounters unpredictable selective processes in the populations from which he draws his samples, and their effects may affect his conclusions. Influences such as mortality and migration may seriously distort the prevalence of chronic disease (Cochrane & Higgins 1961) ; but the epidemiologist's chances of seeing a complete picture are much better than those of the clinician.
With this advantage the epidemiologist has to accept some limitations. The clinician's patients have sought his aid, and are grateful to him for his efforts to elucidate their complaints and ease their distress, so they permit or even expect him to carry out elaborate or even unpleasant investigations. The epidemiologist seeks his subjects at their work or in their homes; they are' in no way obliged to him and may even resent his interference. He must usually restrict his enquiries and investigations to the simplest and least disturbing methods. There are exceptional circumstances when more elaborate and time-consuming tests may be carried out in epidemiological surveys, but as a rule simplicity and brevity are essential.
Lastly, it is hard for the epidemiologist to study rare diseases. The concentration of cases in hospitals provides the clinician with material for the study of which the epidemiologist would have to survey impossibly large populations.
'I believe it is these contrasts that render cooperation between epidemiologists and clinicians so fruitful and they must be emphasized. The following examples of fruitful cross-fertilization between epidemiological and clinical studies are culled largely from my own experience.
In addressing this Section I would naturally like to concentrate on the lessons that epidemiologists may have to learn from clinicians, but there is little to be said about this. The reason, of course, is obvious. All medical epidemiologists have been trained in clinical medicine and their very reason for existence is based upon it. If there were no patients there would be no epidemiology. It is the manifestations of disease in patients which we wish to prevent, and our epidemiological studies are aimed to discover means for this prevention. While we are grounded in clinical medicine many, if not most, clinicians have scarcely encountered epidemiology in their training. They may continue throughout successful clinical careers without ever realizing that-epidemiology has any relevance to their work. For this simple reason the clinician today has more to learn from the epidemiologist than the epidemiologist from the clinician. But epidemiologists must continually bear in mind that epidemiological studies must always be relevant to clinical medicine. Some surveys in which health visitors or lay interviewers are used to collect information from people at home may, as Sanders (1962) has recently emphasized in America, be widely misleading. There are a number of surveys expensive in time and trouble, to which it would be more tactful not to give precise references, in which the information gathered is, when you come down to it, quite unhelpful to the doctor's job of treating and preventing disease. Mere'collection of data is not sanctified by statistical significance if it is clinically immaterial. The clinical phenomenologist may also be tempted into irrelevant physiological or pathological minutia.
In their clinics or in their surveys diagnosis is the first concern for both clinical investigators and epidemiologists, but they have rather different attitudes towards its accuracy. The epidemiologist's need is freedom from diagnostic bias. He needs to compare his findings in one group with those in another group, and he must be sure that any contrasts he observes are real and are not due simply to differences in diagnostic standards. One kind of bias, on the other hand, may even be a source of pride to the clinician. He may claim to diagnose some condition at an earlier stage or more often than do his colleagues whom he regards as less competent than himself. The patients on whom he makes false positive diagnoses will express gratitude for thieir neevitable recovery, so he has no urgent stimulus to correct, this bias. The opposite bias, a false negative, especially in a serious and treatable condition, is the one thing against which the clinician must be on his guard. The epidemiologist, on the other hand, need not worry about occasional false negatives even though they may involve a fatal condition, so long as they are balanced by false positives. Random error, provided it is small, will not spoil his results. For example, the results of an epidemiological survey of the prevalence of cardiac murmurs would not be affected if a case of infective endocarditis were not recognized. But if a clinical investigator did this it might gravely affect the outcome and conclusions of his study and his patient would be endangered.
It is therefore curious that it should have been epidemiologists, concerned with comparing groups, who have paid most attention to the problem of diagnostic accuracy. I first became aware of the problem of observer variation in diagnosis when my colleagues and I in South Wales began to study the natural history of coal workers' pneumoconiosis eighteen years ago. We were concerned, among other problems, with the effect of continued work underground on the progression of pneumoconiosis. We were studying this progression in serial radiographs of men who had and had not worked in the mines during the relevant period. We collected large numbers of films of men before and after periods of work in and out of the mines and read them with confidence and without being aware of much difficulty or disagreement amongst ourselves. We still had the clinician's diagnostic confidence. But then we wanted to discover whether our diagnosis of what was then called 'reticulation' corresponded with that used in the Silicosis Medical Boards, who were diagnosing this at a stage at which it was thought to be necessary to remove men from the mines to prevent further progression. We became concerned with a possible bias between two groups of observers, not with any doubt of our own accuracy. We submitted 100 films to 10 observers, some in our Unit and some in the Silicosis Medical Board. We found astonishing results which have been published (Fletcher & Oldham 1949) . From the epidemiologist's point of view it became immediately apparent that special precautions were needed in order to standardize reading techniques for comparative purposes. Various measures such as careful definition of categories and standard films (Fletcher & Oldham 1951) , duplicate readings and joint readings (Fletcher 1955 ) have now been introduced and statistical techniques for compensating for (Fay & Ashford 1960) or for actually making use of the variation in multiple readings have been developed (Wise & Oldham 1963) . The problem .snow better understood and can be allowed for.
is curious that the lesson of the astonishing variation between individual doctors in their estimate of the amount of pneumoconiosis in X-ray films has not penetrated fully into clinical circles. I still not infrequently see men who have been diagnosed as having pneumoconiosis on the grounds of a single reading of a film by a chest physician. The man has been told that he has the disease and will get a pension from the Ministry of Pensions and National Insurance. If, as is often the case, this is refused the man becomes bitter and inclined to litigation. No doctor should be so presumptuous as to diagnose early simple pneumoconiosis with confidence by himself. He should explain to the patient the difficulty of diagnosis and the possibility of a single reading being wrong. If the man goes to the Pneumoconiosis Medical Panels he should go with an open mind, hopeful but not confident. The Pneumoconiosis Medical Panels themselves, although they use standard films and often use multiple readings, are not instructed to do this in the regulations laid down eight years after the evidence for observer variation in radiological diagnosis of pneumoconiosis was first published. These provide for 'examination and report by one or more medical practitioners' (Ministry of Pensions and National Insurance 1959). There is still no insistence on duplicate reading or on any special method to reduce observer variation or error.
The same resistance is still found in clinical circles to the duplicate reading of all chest films taken for 'screening' purposes, as in miniature mass radiography. I refer particularly to this diagnostic procedure for it is one of the most widespread single investigations on which clinical action may or may not be taken, and it is in this situation that observer variation is of such tfemendous importance. Many papers have been published (Yerushalmy et al. 1950 , Groth-Peterson erta. 1952 , Cochrane & Garland f952, Bauer 1958 showing how-grave and universal the errors in reading chest films are and how well they may be reduced by duiplicate readings. There are a few papers reporting smaller errors under special circumstances (Smith 1956 , Eley & Gough 1960 but the bulk of the evidence suggests a very real need for duplicate reading. Yet this is not advised by the Minister of Health for his mass miniature radiography units or in hospitals and chest clinics. Although its clinical importance has been shown (Stradling & Johnston 1955) it remains exceptional as a routine practice.
But the normal course of clinical diagnosis does not start with radiography. The first step is the clinical history. The epidemiologist has learnt that for group comparisons standardized questions must be used . But how far can or should the clinician adopt the same rigorous technique? Standardization is essential if he wishes to compare his findings with those of other clinicans. I have recently, in collaboration with Dr Benjamin Burrows of the University of Chicago, been trying to see how far the clinical picture of what we call chronic bronchitis in this country compares with what the Americans call emphysema. We did this by taking 50 male patients aged 45-65 in each of our clinics, one of which was called a Bronchitis Clinic, the other an Emphysema Clinic. We took men within an agreed disability range and excluded those with serious complicating diseases. We applied an extension of the standardized respiratory symptom questionnaire (Medical Research Council 1961) to all of these men, measured sputum volume and did a variety of pulmonary function tests. Our main clinical findings are given in Table 1 . Although the distribution of sputum volumes is almost identical in the two clinics, a higher proportion of the British patients said, in answer to a strictly standardized question, that they brought Table 1 Patients' statements about 24-hour sputum volumes and measured volumes at Hammersmith 'Bronchitis Clinic' and Chicago 'Emphysema Clinic' up more than an eggcupful of sputum a day. It is therefore seen that even carefully standardized clinical questions may mislead in comparative studies.
Most clinicians would resist any suggestion that they might use standardized questions in their routine clinical work, and they would have some justification. In his interviews with individual patients the clinician must often attune his questions to their particular needs and responses in order to get an accurate picture of their symptoms. But if he is engaged on any sort of group study, standardization of clinical questions is always desirable, even though standardization of response cannot be assured. In individual clinical work, too, there may be advantages in standardization. It has been shown that a mere printed questionnaire such as the Cornell Medical Index (Brodman et al. 1951 ) may provide useful diagnostic assistance. I suggest that the ideal procedure for the clinician is to start with standardized questions whenever these are applicable and available and to record the direct answers, but then to proceed to supplementary questions to elucidate answers that are uncertain or unsatisfactory. If this were done it might be possible to make much better use of hospital case notes in respect, for instance, of respiratory and cardiac symptoms than at present. These usually have but the barest reference to, say, cough, sputum and dyspncea whose presence or absence are just indicated with a tick or zero mark without any information as to what question was asked and what sort of answer was given.
The basic inaccuracy of clinical questions is an unalterable fact of which the clinician and the epidemiologist must be aware and both have to confirm their clinical observations with objective measurements wherever possible. Clinicians tend to assume that 'a well-taken history' has a special accuracy and even the WHO Expert Committee on -Cardiovascular Diseases (World Health Organization 1959) recommended that a history of angina should be taken 'by an experienced physician'. I suggest that this is wrong and that standardized questions are preferable for epidemiological work, to unstandardized questions, and may often be preferable in clinical work. Rose (1962) has recently shown that his standardized questionnaire on chest pain diagnosed 83% of cases agreed to have angina by three experienced physicians and produced no false positives. It also appeared to be remarkably free from observer variation. I have recently circularized more than 200 doctors all over the world, who had written to ask for the MRC standardized respiratory symptom questionnaire, to enquire about their use of it and to ask for their comments. It has been gratifying to discover that many of them are finding it useful in routine clinical work. This is not really surprising, for these standardized questions and those of Rose have been developed and validated by intensive clinical and extensive epidemiological enquiry and they are likely to be better orientated and more valid and discriminatory than the untested and variable questions used by individual clinicians. The difficulty is that standardized questions are available for so few aspects of clinical work. There is no reason why they should not be developed in other fields than that of respiratory and cardiovascular symptoms. Such development would be a fruitful field for co-operation between clinicians and epidemiologists.
In whatever way the presence of a symptom or physical sign may be established there remains the important question of its present and future significance. Is the sign a real indicator of disease? What prognosis does it carry?
The first of these questions is really one of validation. This can only be done by comparing the frequency of a sign or symptom in subjects known on independent grounds to have or not to have the condition of which the sign is an indicator. This sort of validation may often be done quite readily on clinical material, especially if morbid anatomical verification is possible, but if we are concerned with the earliest sign of any disease it may be possible and certainly preferable to use the sort of general healthy population to which the epidemiologist often has access. I have described an example of this elsewhere in the validation of the earliest radiological signs of pneumoconiosis (Fletcher 1960) .
Apart from validation of an individual sign there is the more important question of establishing whether or not an abnormality encountered in the clinical environment is or is not a cause of some form of disablement or disease, and if so, how closely it is associated. I can again best provide an example of this question from my experience in pneumoconiosis. If a miner with a grossly abnormal X-ray due to pneumoconiosis complains of dyspnoea it is natural to attribute the dyspncea to the pneumoconiosis. Indeed this assumption has been made for many years by clinicians and by doctors concerned with awarding compensation and disability benefit, and yet epidemiological study has shown that this assumption is in many respects incorrect. Studies of the relationship between radiological abnormality and ventilatory capacity (impairment of which is the cause of breathlessness in miners) has shown that there is little association between the severity of radiological evidence of simple pneumoconiosis and loss of ventilatory capacity (Cochrane & Higgins 1961) . It is true that this relationship between radiological stage and ventilatory capacity is slightly different in different mining areas. These differences are presumably due to effects of migration and other factors which may distort the apparent relationship between two variables, one of which may be associated with or actually affect liability to migrate; but there is no suggestion of any significant disabling effect of simple pneumoconiosis within any complete mining community. It should be noted that a slight positive relationship has been observed in working miners (Rogan et al. 1961) , those with advanced simple pneumoconiosis having slightly reduced ventilatory capacity. There are many possible reasons for this discrepancy but the important fact is that, if there is any disabling effect of simple pneumoconiosis, it is extremely smallmuch too small to be of clinical significance. Only studies of complete communities of miners past and present, employed and unemployed, fit and disabled, have made it possible to reach this conclusion and correct the clinical and pathological fallacy. Cochrane & Higgins (1961) have, indeed, been able to go further and show that significant impairment of ventilatory capacity does not arise even in men with progressive massive fibrosis until the shadows in a chest X-ray extend over an area exceeding 20 sq. cm. In men with evidence of impaired ventilatory capacity but with a lesser abnormality than this it is necessary to look elsewhere than at the pneumoconiosis to explain the disability.
Just as epidemiology can present a correct picture of the relationship between abnormalities within a single disease so can it show more surely than is possible in the clinic or hospital whether or not an association between separate abnormalities is due to some genuine association or is a chance affair. Epidemiological study is the surest way to establish the validity of syndromes. A particularly good example of this was the demonstration in the Rhondda Valley that a particular type of X-ray of pneumoconiosis was associated with rheumatoid arthritisthe Caplan Syndrome (Miall et al. 1953) . Moreover it was possible further to investigate this association in the field and to show that both the pulmonary and arthritic changes were manifestations of an inherited rheumatoid diathesis which might manifest itself in either lungs or joints or both (Miall 1955) .
The so-called natural history of disease has always been of great interest to the clinician. That great clinician who later moved on into social medicine and epidemiology, Sir John Ryle, is perhaps today best remembered by his book 'The Natural History of Disease'. In this he describes in elegant terms the natural history of a number of diseases as the clinician saw them in his day. Excellent as are the histories he recounts they are told only from the time at which the patient first sought medical aid for his symptoms. The clinician can only probe the whole course of events that led up to this presentation through the mists of his patient's inaccurate recollection. Often these recollections appear to be so specific as to suggest accuracy but they may be quite spurious. There is a great tendency for people to attribute the onset of disease to some specific episode. Symptoms which may have been mild and gradually increasing may be forgotten before an occasion such as an emotional shock, or an illness, after which the patient becomes aware of them and attributes their onset to the incidentalepisode. In this way a misleading picture of the course may be built up and false wtiological conclusions may subsequently be drawn from the false picture that has been painted.
Epidemiological studies are required to disclose the complete natural history of any disease. It is true, as I have said, that this can be done effectively only in common disorders. Attempts to study rarities, as in a recent study of disseminated lupus erythematosus in New York City (Siegel et al. 1962) , result in a mere collection ofclinicaldata and add nothing to what is already known.
What is needed is a population of size adequate to produce enough cases of the disease under study within a reasonable time, and of stability sufficient to maintain itself over the intended period of study. In this country we have seen the pioneer long-term studies of pneumoconiosis and tuberculosis in the Rhondda Valley by Professor Cochrane. In the USA one thinks immediately of the great Framingham project and the similar enterprise at Tecumseh, or the study by Dr Ogilsby Paul on a large industrial population in Chicago. This is the particular field of investigation in which I am myself engaged and I would like briefly to describe the aims and methods of my present study. The main problem in relation to the natural history of the disease which we call chronic bronchitis is the interrelationship between its three main manifestations: bronchial hypersecretion (or simple chronic bronchitis), recurrent or persistent bronchial infection (or infective chronic bronchitis) and diffuse obstruction to bronchial airflow which is the cause of the bronchitic's breathlessness. Clinical histories sug-gest t-hat persistent breathlessness often begins after an acute bronchial or pulmonary infection and pathologists have reported an association, which they consider to be causal, between bronchiolar inflammation and emphysema (Reid 1954 , Leopold & Gough 1957 , and it is assumed that it is the emphysema that is responsible for the breathlessness. Prevalence surveys have shown a quantitative relationship between the severity of bronchial hypersecretion, frequency of recurrent chest illnesses, and impairment of ventilatory capacity (Clifton 1957 ). It has been assumed that the bronchial hypersecretion impairs the defences of the bronchial tree against infection and' that this infection damages the bronchi and respiratory tissue, producing airways obstruction and emphysema. But there is really no valid evidence to substantiate this hypothesis. The man who dates his breathlessness from an acute bronchitis may have previously had severe airways obstruction, for we know this can be asymptomatic. It may have'been this obstruction that made him liable to bronchial infection, which may have set up persistent increased bronchial secretion which in turn increased his airways obstruction sufficiently to render it symptomatic. The true story may thus be almost exactly opposite to that suggested by current clinical and pathological hypothesis.
Neither clinician nor pathologist can establish the true time sequence of events. This can only be done by actually watching them contemporaneously, making serial measurements of the three main variables, hypersecretion, infection and airways obstruction, in an initially asymptomatic population. These measurements can be made by both subjective and objective methods, although there are methodological problems to be solved. Since we do not really know how or in what way repeated enquiry about the same symptoms may affect their apparent prevalence, reliance must be placed on more objective methods. Sputum volume can be measured, and purulence graded with reasonable accuracy (Miller & Jones 1963 ) and simple methods of ventilatory capacity provide an index of developing airways obstruction. The latter is fortunately a highly repeatable measure and should be able to detect relatively small changes. Measurements of sputum volume depend upon subjects' co-operation in expectorating sputum into a container and we have found these 'measurements have considerable variability, so. it will be more difficult to detect changes in this'paramneter. We are encountering some difficulty. in classifying .and recording the severity of the. very wid,, spectrum of 'chest ill-;nesses'. b4' .,w,hiih t,e o,r ja working man is affected. What has already become apparent is that in the course of many of these illnesses, which we had thought were manifestations of bronchial infection, there is in fact no change in the character, nor often of the volume of the sputum.
We have been making serial measurements now for two years on nearly a thousand working men aged 30-59, but I cannot yet give the answers to any of the main questions we have set ourselves, for the period of observation is still too short. But we have established the willingness of the British workman to collaborate in this repetitive type of study which is quite unrewarding and unexciting to him.
It is my belief that it is reasonable to describe a survey of this kind as 'clinical epidemiology'. Our main object is strictly epidemiologicalto discover contrasts in, for example, the rate of decline of ventilatory capacity or the rate of increase of sputum volume between groups of men with and without frequent 'chest illnesses' who do or do not have purulent sputum, or who do or do not smoke. But we also hope to observe the clinical events in individuals who, apparently healthy at the beginning of the survey, become disabled during its course. There will not be many of these, for studies of the prevalence of disabling bronchitis by decades after the age of 40 suggest an annual attack rate of not more than 1 % (Clifton 1957) . But this should mean that among 1,000 men, observed over five years, we should witness the development of some 50 new cases. We should then be able to describe the early natural history of disabling chronic bronchitis in a series of cases which, although small by many standards, will be enough to act as a signpost and guide to further studies.
The prognosis of established clinical disease is a matter which the clinician should be able to establish by simple follow-up procedures. But no clinician in one hospital can possibly claim that he sees an unbiased sample of all those in a community who are affected by the disorder which he is studying. This difficulty does not imply that all clinical follow-up studies are meaninglessthey may often present a correct picturebut the difficulty is that one can never be sure. The epidemiologist, with access to a complete community, is much more likely to be able to present an accurate and valid account.
There are many recent examples of this. In the Bedford survey of diabetes (Butterfield 1962) clinicians are seeking to explore the pre-symptomatic stages of diabetes by the application of simple clinical tests to a large general population. Follow up of this population' will show the pro-gnostic significance of signs and symptoms of biochemical abnormalities hitherto explored only in the clinic.
Other examples of epidemiology providing the prognostic knowledge that the clinician needs are in the follow up of electrocardiographs in healthy populations (Rumball & Acheson 1963) which is one of the important questions on which the Framingham and Tecumseh studies will throw light, and the studies by Professor Cochrane's team of the prognosis of various forms of pneumoconiosis in South Wales ).
The errors inherent in questions about symptoms, to which I have referred in relation to diagnosis, are of equal importance in assessing the results of treatment. My critical attitude to my patients' subjective responses has recently been sharpened by an epidemiological experience. In our survey of working men we wished to study the reproducibility of measurements of ventil-: atory capacity using the forced expiratory volume, and of measurements of sputum volume. We repeated both these measurements after an interval of ten days. We thought it important to enquire about our.subjects' symptoms to see how much of the variability we might observe was associated with subjective changes in their clinical status and we wished to distinguish this sort of variation from random variation occurring apart from any detectable clinical change. When we repeated the measurements we asked all the subjects whether they were producing more or less phlegm than on the previous occasion, and whether they were more or less wheezy. We found no difference in the mean change of ventilatory capacity in those who said they were more or less wheezy, and there was no difference in the mean sputum volume change in those who said they were bringing up more, the same or less phlegm (Table 2) . Perhaps the situation in a field survey Numbers ofsubjects in brackets like this is different from that in the clinic, but many of the subjects were quite definite in their claims about the changes in their symptoms, and this observation of -the lack of association between subjective and objective evidence of change has made me much more sceptical than I used to be of the reality of symptomatic changes which my patients describe in the absence of objective evidence of a change.
Treatment is the province of the clinician, but the epidemiologist has to face problems of management when he discovers pre-clinical or, undiagnosed examples of diseases in the course of his surveys. There is, of course, little problem if the disease discovered is a serious one, especially if itis one for which effective and: simple therapy is readily available. But where the prognosis of the condition has not yet been worked out satisfactorily (that is to say on the basis of epidemiological study), or where treatment is difficult or of uncertain efficacy, a difficult problem is presented to which no simple answer can be given. It is no good suggesting that the epidemiologist should refer such cases to their own family practitioner for the practitioner probably knows even less about the arguments for and against any form of therapy than does the epidemiologist, although he has the advantage of knowing the patient's background. Of course no action of any kind should be taken without the knowledge and agreement of the family doctor.
The ultimate answer to this sort of problem can only be provided by controlled trials under epidemiological circumstances. A good example of this sort of problem-is that presented by the discovery of many cases of pre-clinical diabetes in elderly subjects in the Bedford survey to which I have already referred, and I understand that a controlled trial of therapy in these cases has now been started which may well be described as clinical epidemiology. Professor Cochrane tells me that he is planning to do a similar study in relation to early glaucoma without visual field defects. It is not difficult to think of other chronic conditions in which combined epidemiological and therapeutic studies are badly needed. appraisal, and the epidemiologist is deprived of the specialist skills of the clinical investigator. They must be brought closer together in their daily work. They need to meet daily in critical and friendly discussion and the epidemiologist should be enabled to place his interests and skills before students within the context of clinical medicine, so that they can come to approve and appreciate both the relevance and interest of epidemiology to their studies.
There is no doubt of this relevance. In the MRC Pneumoconiosis Research Unit, with experimental and epidemiological departments, I have seen epidemiological observations providing ideas for testing in the clinic or laboratory and the laboratory evolving techniques suitable for the epidemiologist. This is the sort of conjunction we need, for the ultimate test of many ietiological and therapeutic hypotheses must lie in human observation or experiment on an epidemiological scale. During the past ten years there have been signs of growing understanding between clinical investigators and epidemiologists, but there is still much too much separation.
It is ten years since the late Sir James Spence in his delightful lecture on the methodology of clinical science wrote: 'If clinical research is to be used to get a full picture of disease, it must equip itself to carry observations beyond the hospitals and extend the researches which can best be done in family practice and by field survey of random samples of population. The methodology of planned clinical observation in family practice and in random samples of the population will become a responsibility of medical schools ... If they fail it is difficult to see how else it can be done' (Spence 1953) . I consider it may be one of the more important functions of the Section of Epidemiology and Preventive Medicine to help in this task by continuing to organize at regular intervals meetings which will advance mutual understanding and co-operation between clinicians and epidemiologists, and thereby contribute to the effectiveness of research into both the treatment and prevention of disease. 
